Table 2 Clinical characteristics of 39 HER2+ patients
From: Amplification of HER2 is a marker for global genomic instability
Sample | Date Diagnosis | Stage Diagnosis | Trastuzumab | Statusa |
|---|---|---|---|---|
1 | 2003 | IIA | No | NED |
2 | 2003 | IIB | No | DOD |
3 | 2003 | IIA | Yes | NED |
4 | 2003 | IIA | No | NED |
5 | 2005 | I | Yes | NED |
6 | 2003 | IIA | Yes | DOD |
7 | 2004 | IIA | No | NED |
8 | 2004 | I | No | NED |
9 | 2004 | IV | Yes | AWD |
10 | 2004 | IIIA | Yes | AWD |
11 | 2004 | IIIA | Yes | NED |
12 | 2004 | IIIC | Yes | AWD |
13 | 2004 | I | No | NED |
14 | 2004 | I | No | NED |
15 | 2004 | IIIC | Yes | NED |
16 | 2004 | IIIA | Yes | NED |
17 | 2001 | IIB | No | NED |
18 | 2001 | I | No | NED |
19 | 2002 | I | No | NED |
20 | 2002 | IIA | No | UNK |
21 | 2002 | IIIA | No | NED |
22 | 2002 | I | No | NED |
23 | 2002 | I | No | NED |
24 | 2002 | IIB | No | NED |
25 | 2003 | IIIC | No | NED |
26 | 2003 | IIA | No | NED |
27 | 2005 | I | No | NED |
28 | 2004 | IIA | No | NED |
29 | 2005 | IIIA | No | NED |
30 | 2005 | I | No | NED |
31 | 1996 | IIIB | No | DOC |
32 | 2002 | I | Unknown | NED |
33 | 2003 | I | Yes | NED |
34 | 1992 | IIA | No | NED |
35 | 1993 | IIIA | No | DOD |
36 | 1994 | I | No | NED |
37 | 1995 | I | No | DOC |
38 | 1995 | I | No | DOD |
39 | 1996 | IIB | No | NED |